# Treatment Patterns Among Patients With Venous Thromboembolism in the United States

> **NCT05795062** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 13945 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** apixaban
- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT05795062
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-10
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 13945 (ACTUAL)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05795062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05795062, "Treatment Patterns Among Patients With Venous Thromboembolism in the United States". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05795062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*